MicroRNAs From Blood Samples as Biomarkers for Gastric Cancer Detection
- Conditions
- MicroRNAsGastric Cancer
- Interventions
- Diagnostic Test: MicroRNA
- Registration Number
- NCT05901376
- Lead Sponsor
- King Chulalongkorn Memorial Hospital
- Brief Summary
The goal of this observational study is to compare specific microRNA levels from the plasma of gastric cancer patients and healthy volunteers to see if there is an upregulated expression in gastric cancer patients.
The main question it aims to answer is:
- Can microRNAs be effectively used as diagnostic biomarkers for gastric cancer?
Participants will be asked for their consent to obtain 5 cc of blood.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 280
Not provided
- Patients who cannot give informed consent
- Pregnancy
- Lymphoma
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Control MicroRNA - Gastric Cancer MicroRNA -
- Primary Outcome Measures
Name Time Method The different of MiR-21 level between gastric cancer and control group Day 1 The different of MiR-21 level between gastric cancer and control group
The different of MiR-223 level between gastric cancer and control group Day 1 The different of MiR-223 level between gastric cancer and control group
The different of MiR-106b level between gastric cancer and control group Day 1 The different of MiR-106b level between gastric cancer and control group
The different of MiR-199a level between gastric cancer and control group Day 1 The different of MiR-199a level between gastric cancer and control group
The different of MiR-20a level between gastric cancer and control group Day 1 The different of MiR-20a level between gastric cancer and control group
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
King Chulalongkorn Memorial Hospital
🇹ðŸ‡Bangkok, Not Required For This Country, Thailand